#rna #drugdiscovery #startup #fundraising #announcement | Jason Fontana | 27 comments
Summary
I am very happy to share that Wayfinder Biosciences raised $2.5m from Exor Ventures to accelerate the development of our platform to drug RNA. Over the past year, weve been hard at work building Wayfinders RNA sensor technology to discover new small molecules that target RNA. With our powerful lens into RNA design and a platform to generate uniquely rich, proprietary datasets on RNA binding, we believe our platform is primed to develop effective and selective therapeutics for undruggable diseases. Im proud of the work the team has been doing, making fast strides towards our upcoming campaigns and hitting our internal milestones. We see Exor Ventures showing of insider support as strong validation of our progress and Im excited to deepen our partnership.